IP Library Granted Patent US 7,425,446
Granted Patent B2
US 7,425,446 · App. 11/287,359 · Granted Sep 16, 2008

Antibody composition-producing cell

View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,425,446
App. No.
11/287,359
Granted
Sep 16, 2008
Kind
B2
Abstract

The present invention relates to a cell for the production of an antibody molecule such as an antibody useful for various diseases having high antibody-dependent cell-mediated cytotoxic activity, a fragment of the antibody and a fusion protein having the Fc region of the antibody or the like, a method for producing an antibody composition using the cell, the antibody composition and use thereof.

Claims (6)

1. An isolated mammalian host cell which has decreased or no α1,6-fucosyltransferase activity for adding fucose to N-acetylglucosamine of a reducing terminus of N-glycoside-linked sugar chains by deleting a gene encoding α1,6-fucosyltransferase or by adding a mutation to said gene to reduce or eliminate the α1,6-fucosyltranferase activity, wherein said mammalian host cell produces an antibody molecule.

2. The isolated host cell of claim 1 , wherein said host cell is a CHO cell.

3. The isolated host cell of claim 1 , wherein said host cell is a NS0 cell.

4. The isolated host cell of claim 1 , wherein said host cell is a SP2/0 cell.

5. The isolated host cell of claim 1 , wherein said host cell is a YB2/0 cell.

6. The isolated host cell of claim 1 wherein said antibody molecule is an IgG antibody.

Assignments (1)
CHANGE OF NAME AND ADDRESS Recorded Oct 23, 2019
From: KYOWA HAKKO KIRIN CO., LTD.
To: KYOWA KIRIN CO., LTD.
Reel/Frame 050797/0533 →